• 1
    Working Group of the Australian and New Zealand Bone and Mineral Society, Endocrine Society of Australia and Osteoporosis Australia. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust 2005; 182: 2815.
  • 2
    Qaseem A, Snow V, Shekelle P, Hopkins R Jr, Forciea MA, Owens DK. Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2008; 149: 40415.
  • 3
    Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 26681.
  • 4
    Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE et al. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 2010; 21: 11514.
  • 5
    IARC. Vitamin D and Cancer. Vitamin D and Cancer, Working Group Reports Volume 5. Lyon: World Health Organisation International Agency for Research on Cancer; 2008.
  • 6
    Vitamin D External Quality Assessment Scheme (DEQAS). 25 Hydroxyvitamin D October 2009 Distribution 2009.
  • 7
    Zerwekh JE. Blood biomarkers of vitamin D status. Am J Clin Nutr 2008; 87: 1087S91S.
  • 8
    de la Hunty A, Wallace AM, Gibson S, Viljakainen H, Lamberg-Allardt C, Ashwell M. UK Food Standards Agency Workshop Consensus Report: the choice of method for measuring 25-hydroxyvitamin D to estimate vitamin D status for the UK National Diet and Nutrition Survey. Br J Nutr 2010; 104: 61219.
  • 9
    Binkley N, Krueger D, Cowgill CS, Plum L, Lake E, Hansen KE et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab 2004; 89: 31527.
  • 10
    Glendenning P, Taranto M, Noble JM, Musk AA, Hammond C, Goldswain PR et al. Current assays overestimate 25-hydroxyvitamin D-3 and underestimate 25-hydroxyvitamin D-2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays. Ann Clin Biochem 2006; 43: 2330.
  • 11
    Roth HJ, Schmidt-Gayk H, Weber H, Niederau C. Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Ann Clin Biochem 2008; 45: 1539.
  • 12
    Harrison SL, Nowak M, Buettner PG, Kimlin MG, Porter D, Kennedy RL et al. Public health and clinical dilemmas resulting from imprecise vitamin D tests. J Rural Trop Public Health 2009; 8: 528.
  • 13
    Lucas RM, Ponsonby AL, McMichael AJ, van der Mei I, Chapman C, Coulthard A et al. Observational analytic studies in multiple sclerosis: controlling bias through study design and conduct. The Australian Multicentre Study of Environment and Immune Function. Mult Scler 2007; 13: 82739.
  • 14
    Maunsell Z, Wright DJ, Rainbow SJ. Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 2005; 51: 168390.
  • 15
    Fleiss JI. Statistical Methods for Rates and Proportions, 2nd edn. New York: John Wiley & Sons Inc; 1981.
  • 16
    Carter GD, Carter CR, Gunter E, Jones J, Jones G, Makin HL et al. Measurement of vitamin D metabolites: an international perspective on methodology and clinical interpretation. J Steroid Biochem Mol Biol 2004; 89–90: 46771.
  • 17
    Carter GD, Jones JC. Use of a common standard improves the performance of liquid chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-D. Ann Clin Biochem 2009; 46: 7981.
  • 18
    Carter GD. 25-Hydroxyvitamin D assays: the quest for accuracy. Clin Chem 2009; 55: 13002.
  • 19
    Binkley N, Krueger D, Gemar D, Drezner MK. Correlation among 25-hydroxy-vitamin D assays. J Clin Endocrinol Metab 2008; 93: 18048.
  • 20
    Cavalier E, Rozet E, Gadisseur R, Carlisi A, Monge M, Chapelle JP et al. Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: impact on the clinical cut offs. Osteoporos Int 2010; 21: 104751.
  • 21
    Lai JK, Lucas RM, Clements MS, Harrison SL, Banks E. Assessing vitamin D status: pitfalls for the unwary. Mol Nutr Food Res 2010; 54: 106271.
  • 22
    Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 30710.
  • 23
    Medicare Australia. Statistical Reports for Item 66608: Vitamin D or D Fractions. Canberra: Australian Government; 2010.
  • 24
    Lucas RM, Ponsonby A-L, Dear K, Valery PC, Pender MP, Taylor BV et al. Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology 2011; 76: 5408. (in press).
  • 25
    Phinney KW. Development of a standard reference material for vitamin D in serum. Am J Clin Nutr 2008; 88: 511S12S.